Glizest-MV 80.3 SR Tablet
Gliclazide 80 mg + Metformin 500 mg + Voglibose 0.3 mg (Sustained Release)
| Composition | Gliclazide 80 mg + Metformin 500 mg + Voglibose 0.3 mg (Sustained Release) |
|---|---|
| Dosage Form | Tablet |
| Pack Type | Box |
| Pack Size | 10 x 15 (Blister) |
| MRP | ₹ 2550 |
| Therapy | Cardiac + Diabetic — Second-generation sulphonylurea (Gliclazide-based) |
| Storage | Store below 25°C. |
📱 WhatsApp Enquiry📞 Call: +919041677932
About Glizest-MV 80.3 SR Tablet
Glizest-MV 80.3 SR Tablet contains Gliclazide 80 mg + Metformin 500 mg + Voglibose 0.3 mg (Sustained Release). Gliclazide is a second-generation sulphonylurea with additional antioxidant and antiplatelet properties — making it particularly useful in type-2 diabetic patients with cardiovascular risk.
Indicated for adult type-2 diabetes mellitus inadequately controlled by lifestyle measures alone or in combination with metformin / other oral agents.
Camrut Healthcare manufactures the Glizest range under WHO-GMP conditions for PCD pharma franchise across India.
Indications
- Type-2 diabetes mellitus
- Adjunct to metformin
- Diabetic patients with vascular risk (gliclazide's antioxidant benefit)
Mechanism of Action
Gliclazide is a second-generation sulphonylurea that stimulates pancreatic beta-cell insulin secretion by closing ATP-sensitive K+ channels (SUR1). It also has antioxidant and antiplatelet effects via free-radical scavenging and reduced platelet aggregation — providing additional benefit in diabetic vascular complications.
Dosage & Administration
['Adults: 1 tablet once daily before breakfast (or as advised)', 'Titrate based on glycaemic response', 'Maximum 320 mg/day total gliclazide', 'MR tablets: swallow whole, do not crush']
Side Effects
['Hypoglycaemia', 'Weight gain (mild)', 'GI upset', 'Skin reactions (rare)', 'Cholestatic jaundice (rare)']
Contraindications & Precautions
['Type-1 diabetes', 'Diabetic ketoacidosis', 'Severe hepatic/renal impairment', 'Pregnancy and breastfeeding', 'Sulphonamide hypersensitivity']
Storage
Store below 25°C.
Glizest-MV 80.3 SR Tablet is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →
Frequently Asked Questions
q
a
q
a
q
a
q
a
q
a
Related Products
- Glizest-60 SR Tablet — Gliclazide 60 mg (Modified Release)
- Glizest-M 60/500 SR Tablet — Gliclazide 60 mg + Metformin 500 mg
- Glicam-2 Tablet — Glimepiride 2 mg